Novel neutralizing immunogen (NimIV) of rhinovirus and its use for vaccine applications

Details for Australian Patent Application No. 2007318206 (hide)

Owner Sanofi Pasteur Biologics Co.

Inventors Kleanthous, Harold; Kalnin, Kirill; Yan, Yanhua

Agent Pizzeys

Pub. Number AU-A-2007318206

PCT Pub. Number WO2008/057158

Priority 60/848,451 29.09.06 US

Filing date 1 October 2007

Wipo publication date 15 May 2008

International Classifications

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/057158 Priority application(s): WO2008/057158

4 June 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 27 Apr 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007318208-Compositions and multiplex assays for measuring biological mediators of physiological health

2007318200-Chucks and use in processing toroidal structures